HEALTH TECHNOLOGY

ClearDATA Announces Support for the Amazon Web Services for Health Initiative

Anurag Khadkikar | July 16, 2021

ClearDATA Announces Support for the Amazon Web Services for Health Initiative

ClearDATA, healthcare's trusted partner for protecting sensitive patient data in the cloud, announced support for Amazon Web Services (AWS) AWS for Health initiative to drive the industry's digital transformation - securely and compliantly. As a result, Healthcare and life sciences organizations can now easily use the power of advanced AWS cloud services by using ClearDATA to operationalize their privacy and security measures and accelerate the deployment of their applications.

 

AWS for Health is a project that includes services and solutions developed specifically for healthcare, biopharma, and genomics clients by AWS and AWS Partners. The initiative makes it simpler for health customers throughout the health community to choose the appropriate tools and partners for their highest-priority workloads. AWS for Health also identifies specialized AWS health industry experts, AWS Professional Services teams, and top AWS Partners in each solution area for clients seeking to accelerate deployments with solution-specific assistance.

 

Companies across the healthcare spectrum – from digital Health to providers, payers, and life sciences – have long struggled to balance the critical need to modernize their IT infrastructure and develop modern cloud-based solutions with inherent ethical and legal obligations to protect patient privacy and data integrity. By partnering with ClearDATA, healthcare organizations can operationalize their privacy and security practices, leveraging automated controls and remediation and sophisticated threat intelligence and services for the rapid deployment and management of a continuously compliant IT infrastructure.

 

ClearDATA's HITRUST-Certified Healthcare Privacy and Security Management Platform and services were created to help healthcare organizations accelerate the deployment of modern cloud initiatives and applications and configure AWS HIPAA Eligible Services to securely handle Protected Health Information (PHI) and other sensitive data. The solution accomplishes this by providing developers with direct access to AWS. At the same time, ClearDATA's technology and services impose technical restrictions to comply with privacy regulations and proactively protect the healthcare sector from the recent onslaught of attacks.

 

ClearDATA's integrated privacy and security controls allow healthcare organizations to reduce time to market by quickly having their applications up and running in the cloud, beginning with design and continuing throughout the runtime.

 

About ClearDATA

Healthcare professionals worldwide rely on the ClearDATA HITRUST-certified cloud to protect their sensitive data and power critical applications that are accessible on all major public cloud platforms. Customers in the healthcare sector benefit from one of the most comprehensive Business Associate Agreements (BAA) in the industry and market-leading healthcare-exclusive security and compliance solutions and multi-cloud expertise. ClearDATA's innovative platform of solutions and services safeguards customers' data privacy, improves data management, and expands their healthcare IT infrastructure, allowing them to focus on enhancing healthcare delivery every day.
 

Spotlight

Care 4 a Health I.E. brings local organizations and volunteers together to care for the health and well-being of people in the community. The 2012 Care 4 a Healthy I.E. event that provided free medical, dental and acupuncture services to more than 2,400 Inland Empire residents was made possible by more than 50 local agencies, 175 health care professionals and hundreds of volunteers to serve and care for those who needed it most. We need YOU for the 2013 event. Health care professionals, community based organizations and volunteers can learn how to get involved by emailing C4AHC@molinahealthcare.com or by calling 1-800-232-9998 ext. 128091.


Other News
HEALTH TECHNOLOGY

PulsePoint Releases Next Generation Health Media Platform With Advanced Automation And AI

PulsePoint | July 06, 2021

PulsePoint, a technology company revolutionizing health decision-making in real-time, today announced the next generation launch of its digital media buying platform, Life by PulsePoint™. Its enhanced AI and automation simplifies and supercharges the media planning, activation, and optimization processes. Designed for the self-serve programmatic trader, these updates promote efficiencies and surface predictive and in-flight campaign analytics for quick strategic decisioning to yield higher media return on investment. Built upon PulsePoint's extensive data foundation, Genome™, that proactively uses microdata to capture attention when intent is signaled, Life is the leading healthcare end-to-end programmatic platform. Life's automated machine learning and AI allows marketers to quickly create highly-customized segments that classify populations in real-time, and deliver sequential messaging to drive customer actions in the moment and across the health journey. This next generation of the Life platform includes: • Advanced media planning innovations: Life offers an AI-powered forecasting tool used to run simulations to generate predictive performance metrics and intelligent audience insights. This makes it easier for marketers to preview budgets and ideate and adjust tactics to obtain their desired campaign outcomes, all before a single dollar is spent. Each forecast is powered by detailed supply and channel insights, like expected delivery, and campaign performance can be viewed by a variety of dimensions, including creative types, domains/apps, condition categories, healthcare professional specialties, geographies, among others. • Better campaign management with advanced dashboard: An automated and real-time view of line item performance and pacing gives traders a deeper, more granular look into their campaigns, making it easier for them to optimize their spend based on flight delivery and anticipate new incremental opportunities. The dashboard not only surfaces key numbers, but it also includes dynamic performance charts to uncover real-time campaign insights. • Turnkey PMP (private marketplaces) deal builder: Enhanced with turnkey end-to-end functionality, self-serve traders can now enable the deals that they negotiated directly with publishers and/or SSPs through Life's UI, decreasing the time it takes to launch PMPs. "Life was built for the healthcare marketer to simplify and optimize marketing campaigns," said Andrew Stark, CRO of PulsePoint. "Our newest capabilities increase efficiencies through advanced forecasting and real-time performance optimization, enabling more control and enhanced campaign management." Life by PulsePoint provides access to over 110 billion daily impressions across more than 2 million health pages, reaching 1.8M+ opted-in, verified healthcare professionals and over 90% of the online U.S. population. This release is just another step in PulsePoint's journey to deliver personalized messaging at each stage of the health journey using predictive insights built on real-time data. The company was recently acquired by Internet Brands, a KKR portfolio company and owner of WebMD Health Corp. PulsePoint's teams will continue to operate as their own division from their existing hubs in New York, San Francisco, and London. About PulsePoint PulsePoint is a leading technology company that uses real-world data in real-time to optimize campaign performance and revolutionize health decision-making. Leveraging proprietary datasets and methodology, PulsePoint targets healthcare professionals and patients with an unprecedented level of accuracy—delivering unparalleled results to the clients we serve.

Read More

HEALTH TECHNOLOGY

Future Health announced today that it has completely digitalised its annual in-person event at ExCeL London

Future Health | March 02, 2021

Future Health has completely rebranded during lockdown, and the flagship face-to-face event Future Health Innovations at ExCeL is now complemented by a global virtual conference series, under the brand UK Health Week. Free for delegates to attend, it is CPD and CME accredited. Participants will be able to connect, meet buyers and partake in cross border purchasing, education and deal making, enabling an increased ROI and profitable encounters with its AI powered networking software. Further Health Weeks are being rolled out around the world over the course of the coming months, and will be territory specific. Dawn Barclay-Ross, Event Director commented: “I think there will always be a place for face-to-face events; and we are contracted with ExCeL for a live ‘in person’ event four years in advance to 2025. However, as a result of international travel restrictions, health professionals in global markets are looking for on-line engagement”. Future Health offers buyers and sellers the ability to operate on line, and to research and access the products and services that their hospitals and citizens desperately need. Dawn concluded, “In the immediate post COVID era, health buyers want to be able to operate from the comfort of their desk or smart device, and they now can, from literally anywhere in the world”. AboutFuture Health Future Health is an independent exhibition and conference organiser, based in London in the UK. For further information regarding exhibiting, visiting and sponsorship opportunities at Future Health Innovations or UK Health Week Please call +44 (0) 208 012 8511 Email: hello@futurehealthinnovations.com or to sign up to the Future Health platform, register at www.futurehealthinnovations.com

Read More

HEALTH TECHNOLOGY

L2Mtech GmbH Receives CE Mark Approval on 6(SIX) products for Cardiovascular and Endovascular Applications

L2Mtech | February 17, 2021

CE Mark Approval for LimusTrack™, Sirolimus Eluting Coronary Stent System for Cardiovascular Applications. CE Mark Approval for LomiFlow™, Paclitaxel Drug Eluting Balloon for Cardiovascular Applications CE Mark Approval for PearlFlow™, Paclitaxel Drug Elutin Balloon for Endovascular Applications CE Mark Approval for PearlFlow NS™, Self Expandable Nitinol Stent System for Endovascular Applications CE Mark Approval for FlexiTrack 018™, Peripheral Balloon Catheter for Endovascular Applications CE Mark Approval for FlexiTrack 035™, Peripheral Balloon Catheter for Endovascular Applications Bonn, Germany – L2Mtech GmbH has announced the award of its first CE Mark approval on Six (6) products: LimusTrack™ : Sirolimus Coated Cobalt Chromium Stent with biodegradable polymer for the treatment of coronary artery disease, de novo lesions, restenosis lesions. LomiFlow™ : Paclitaxel Coated balloon catheter for the treatment of coronary artery disease, small vessels, dilatation of de novo lesions, in-stent restenosis (ISR) cases. PearlFlow™ : Paclitaxel Coated balloon catheter for the treatment of peripheral arterial disease, PTA, dilatation of stenotic segments or lesions in peripheral arteries. PearlFlow NS™ : Self-Expanding Nitinol Stent System for the treatment of peripheral arterial disease, de novo lesions, lesions in femoropopliteal arteries. FlexiTrack 018™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in femoral, popliteal, tibial arteries. FlexiTrack 035™ : Peripheral Balloon Dilatation catheter for the treatment of peripheral arterial disease, dilatation of lesions in the SFA, femoral arteries. L2Mtech GmbH Founder and CEO Lalit Mamtani said ‘‘We are very excited to have been awarded our first CE Mark on six products, CE Mark approval represents a key milestone for L2Mtech GmbH and is a testament to the efficacy and safety of our innovative technology products for Cardiovascular and Endovascular applications.“ We now prepare to commercially launch the products in all markets where the CE Mark is recognized. With introduction of our innovative technology products in markets, we will be able to expand treatment options for the benefit of many millions of patients with coronary and peripheral artery disease around the world. About L2Mtech Founded in 2017, L2Mtech GmbH is a privately-owned multinational medical device company headquartered at Bonn, Germany. L2Mtech specializes in design, development, manufacture and commercialization of medical devices that are used by healthcare establishments globally. L2MTech will provide interventional physicians with innovative vascular devices including Drug Eluting Balloon manufactured in Europe.Our Core mission is to build a product portfolio focused on minimally invasive treatment for patients with cardiovascular,endovascular and vascular artery disease. For further information, please visit : L2MTech.de Media Contact: L2Mtech GmbH admin@L2Mtech.de +49 228 94730761

Read More

CMS to pay providers via MIPS for participating in COVID-19 drug treatment trials

CMS | April 21, 2020

Clinicians can earn a credit via the Merit-based Incentive Payment System (MIPS) if they participate in a clinical trial and report clinical information on COVID-19, the Trump administration announced late Monday. The Centers for Medicare & Medicaid Services (CMS) said Monday that the goal of the new credit is to provide data that will be vital to making treatments to combat the virus. “The best scientific and medical minds in the world are working night and day to find treatments to combat coronavirus,” CMS Administrator Seema Verma said in a statement Monday. “But without solid data, their efforts are liable to run against a brick wall.”

Read More

Spotlight

Care 4 a Health I.E. brings local organizations and volunteers together to care for the health and well-being of people in the community. The 2012 Care 4 a Healthy I.E. event that provided free medical, dental and acupuncture services to more than 2,400 Inland Empire residents was made possible by more than 50 local agencies, 175 health care professionals and hundreds of volunteers to serve and care for those who needed it most. We need YOU for the 2013 event. Health care professionals, community based organizations and volunteers can learn how to get involved by emailing C4AHC@molinahealthcare.com or by calling 1-800-232-9998 ext. 128091.

Resources

Events